Eli Lilly has committed to setting a new standard for on-screen representation of common chronic diseases, and it walked the walk with its recent sponsorship of a segment on “Project Runway.” In the ...

Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...

Oct 6 (Reuters) - Eli Lilly (LLY.N), opens new tab will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, ...

Eli Lilly is calling on European countries to make “urgent improvements” to their Alzheimer’s disease diagnostic testing practices just weeks after nabbing a new approval on the continent for its ...

Oct 8 (Reuters) - Telehealth company HealthTap said on Wednesday it is joining Eli Lilly's (LLY.N), opens new tab digital healthcare platform, LillyDirect, to offer virtual diabetes management ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Peter Marks, the ...

Amid Eli Lilly's efforts to strengthen its global manufacturing network, the Indianapolis pharma giant is splashing more than $1 billion into its Indian operations, with plans to tap local partners ...

Eli Lilly (NYSE:LLY) announced positive results from a late-stage trial of Omvoh (mirikizumab-mrkz) for patients suffering from moderately to severely active ulcerative colitis. The study demonstrated ...

Eli Lilly: Was I Too Cautious? We don't get everything right, do we? While I nailed the upgrade in Eli Lilly and Company (NYSE:LLY) stock in my last write-up in August, some of you might contend that ...

(Reuters) -Peter Marks, the former top vaccine regulator who was ousted from the U.S. Food and Drug Administration earlier this year, has joined Eli Lilly, the drugmaker told Reuters on Tuesday. Marks ...